UB Paderborn / Katalog / Suche / in CDI

1 – 14 von 14

Sortiert nach

Causes of mortality in elderly UICC stage III colon cancer (CC) patients––Tumor‐related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP) registry

Cancer medicine (Malden, MA), 2022-04, Vol.11 (8), p.1735-1744

2022

Volltextzugriff (PDF)

First-line bevacizumab-containing therapy for HER2-negative locally advanced/metastatic breast cancer: Real-world experience from >2000 patients treated in the multicentre AVANTI study

Breast (Edinburgh), 2021-12, Vol.60, p.70-77

2021

Volltextzugriff (PDF)

Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors - Results from the PAN Study

PloS one, 2016-07, Vol.11 (7), p.e0159976

2016

Volltextzugriff (PDF)

CONIFER - Non-Interventional Study to Evaluate Therapy Monitoring During Deferasirox Treatment of Iron Toxicity in Myelodysplastic Syndrome Patients with Transfusional Iron Overload

Oncology research and treatment, 2016, Vol.39 (7-8), p.424-431

2016

Volltextzugriff (PDF)

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

The lancet oncology, 2017-09, Vol.18 (9), p.1159-1171

2017

Volltextzugriff (PDF)

Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies

Clinical colorectal cancer, 2018-12, Vol.17 (4), p.e617-e629

2018

Volltextzugriff (PDF)

Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study

BMC cancer, 2014-12, Vol.14 (1), p.897-897, Article 897

2014

Volltextzugriff (PDF)

Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)

JTO clinical and research reports, 2024-04, Vol.5 (4), p.100626-100626, Article 100626

2024

Volltextzugriff (PDF)

Referenz Hämatologie

Volltextzugriff (PDF)

Sa1072 Early Markers of Metabolic Syndrome are Associated With Distinct HCV Genotypes, While Abnormal Glucose Tolerance Substantially Decreases the Likelihood of SVR

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-961-S-961

2012

Volltextzugriff (PDF)

Predictive Factors of Thrombocytopenia in Treatment of Chronic Hepatitis C (CHC) Patients With Peginterferon Alfa-2a (40KD) and Ribavirin

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-948-S-948

2011

Volltextzugriff (PDF)

Pathological Glucose Levels and Presence of Hypertension Identifies HCV Patients With Minor Treatment Responses

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-933-S-933

2011

Volltextzugriff (PDF)

Androstenedione metabolism in cultured human osteoblast-like cells

The journal of clinical endocrinology and metabolism, 1992-07, Vol.75 (1), p.101-105

1992

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(13)
Bücher
(1)

Sprache

Englisch
(13)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(10)
Life Sciences & Biomedicine
(9)
Oncology
(8)
Humans
(7)
Female
(5)
Middle Aged
(5)
Adult
(4)
Aged
(4)
Male
(4)
Aged, 80 And Over
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Chemotherapy
(3)
Clinical Trials
(3)
Colorectal Cancer
(3)
Gastroenterology And Hepatology
(3)
Metastasis
(3)
Patients
(3)
Treatment Outcome
(3)
Colorectal Carcinoma
(2)
Colorectal Neoplasms - Pathology
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effectiveness, safety and quality of life of trifluridine/tipiracil in pretreated patients with metastatic colorectal cancer: Real‐world data from the noninterventional TACTIC study in Germany

Causes of mortality in elderly UICC stage III colon cancer (CC) patients––Tumor‐related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP) registry

First-line bevacizumab-containing therapy for HER2-negative locally advanced/metastatic breast cancer: Real-world experience from >2000 patients treated in the multicentre AVANTI study

Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors - Results from the PAN Study

CONIFER - Non-Interventional Study to Evaluate Therapy Monitoring During Deferasirox Treatment of Iron Toxicity in Myelodysplastic Syndrome Patients with Transfusional Iron Overload

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies

Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study

Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)

Referenz Hämatologie

Sa1072 Early Markers of Metabolic Syndrome are Associated With Distinct HCV Genotypes, While Abnormal Glucose Tolerance Substantially Decreases the Likelihood of SVR

Predictive Factors of Thrombocytopenia in Treatment of Chronic Hepatitis C (CHC) Patients With Peginterferon Alfa-2a (40KD) and Ribavirin

Pathological Glucose Levels and Presence of Hypertension Identifies HCV Patients With Minor Treatment Responses

Androstenedione metabolism in cultured human osteoblast-like cells

Suchergebnisse filtern